CONMED Corporation (CNMD)
NYSE: CNMDHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CNMD stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.39B
- P/E (TTM)
- 19.32
- Forward P/E
- 9.80
- EPS (TTM)
- $2.41
- Dividend yield
- None
- Ex-dividend date
- Sep 15, 2025
- 52-week range
- 31.44 – 54.80
- Day range
- 45.94 – 48.00
- Volume / Avg
- 384.26K / 364.31K
- Beta
- —
- Shares outstanding
- 29.80M
52-week range
CNMD stock today
Shares of CONMED (CNMD) finished higher on Nov 20 at $46.56, a gain of 0.39% or $0.18 per share, versus the S&P 500's 3.70% decline. At this level, CNMD sits in the middle of its 52-week range of $31.44 to $54.80: 15.0% below the high, set on Nov 5, 2026 and 48.1% above the low. CNMD is up 14.7% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 8.8%.
At 19.3x trailing earnings, CONMED trades above the peer-group median of 10.4x. Its forward P/E of 9.8x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About CONMED
Company profileCONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as powered resection instruments, fluid management and visualization systems, and related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name.
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CEO
- Mr. Patrick J. Beyer
- Headquarters
- Largo, FL
- Employees
- 3,900
- IPO year
- 1987
- Website
- conmed.com
Financial highlights
Full financialsIn fiscal 2025, CONMED generated $1.37 billion in revenue, up 5.2% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $47.1 million (-64.5% year over year), for a net margin of 3.4% versus a median of 5.2% in the prior 5 years. Gross margin was 54.6% (down from 56.1%) and operating margin 7.5%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $1.37B | $1.31B | $1.24B | $1.05B | $1.01B |
| Growth | +5.18% | +5.00% | +19.06% | +3.45% | +17.18% |
| Net income | $47.05M | $132.42M | $64.46M | $-80.58M | $62.54M |
| EPS (diluted) | $1.51 | $4.25 | $2.04 | $-2.68 | $1.94 |
Analyst forecast
ForecastConsensus (7 analysts)
hold
Avg. price target
$46.83+0.58%
- Strong buy 0
- Buy 0
- Hold 6
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Oct 28, 2026
- EPS actual vs est.
- $0.66 vs $1.00
- Surprise
- -34.00%
Dividends
Dividend history- Annual dividend
- $0.00
- Last payment
- $0.20
- Ex-dividend date
- Sep 15, 2025
CNMD news
All CNMD news- Here's Why You Should Retain CONMED Stock in Your Portfolio for NowNasdaqCNMD, ISRG, WST, GKOS
- CONMED Reaches Analyst Target PriceNasdaq
- CONMED (CNMD) Q3 2026 Earnings Call TranscriptNasdaq
- Conmed (CNMD) Q3 Earnings Top EstimatesNasdaqCNMD, BDX
- CONMED Q3 Profit Rises, Updates 2026 GuidanceNasdaq
- CONMED Corporation Reports Third Quarter 2026 Financial Results; Updates Full Year 2026 GuidanceBusiness Wire
- Is Cardinal Health Building a New Tech-Enabled Healthcare Platform?NasdaqCAH, CNMD, ALGN
- Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report?NasdaqHSIC, CNMD
CONMED peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CBLLCeriBell Inc. | 27.39 | +6.37% | $1.06B | vs CNMD |
| INMDInMode Ltd. | 12.42 | -2.20% | $714.70M | vs CNMD |
| CVCapsoVision Inc. | 6.11 | -3.17% | $327.56M | vs CNMD |
| ELMDElectromed Inc. | 22.98 | -1.20% | $187.84M | vs CNMD |
| FOCLEDAP TMS S.A. ADR | 2.61 | -7.45% | $123.25M | vs CNMD |
| VANIVivani Medical Inc. | 1.14 | +4.59% | $102.83M | vs CNMD |
| STXSStereotaxis Inc. | 0.9422 | -6.71% | $95.03M | vs CNMD |
| HSDTSolana Company Class A | 1.49 | -10.24% | $93.70M | vs CNMD |
Indexes, lists and sector
CONMED stock FAQ
What is CONMED's stock price today?
CNMD last traded at $46.56 as of Nov 20, 4:00 PM EST, up 0.39% on the day. Prices are delayed at least 15 minutes.
Does CONMED pay a dividend?
Yes. CONMED pays $0.00 per share annually. The most recent dividend of $0.20 had an ex-dividend date of Sep 15, 2025.
What is CNMD's P/E ratio?
CNMD trades at a trailing P/E ratio of 19.32 and a forward P/E of 9.80, compared with a median of 10.4 for its closest peers.
Who is CONMED's CEO?
Mr. Patrick J. Beyer is the chief executive officer of CONMED Corporation, which has about 3,900 employees.
Has CNMD ever split its stock?
Yes. The most recent CNMD stock split was a 3-for-2 split on Sep 10, 2001, one of 3 splits on record.
What is the CNMD 52-week high?
The 52-week high for CNMD is $54.80 and the 52-week low is $31.44. The stock is currently 15.0% below its high.